- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer.
September 18, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.
September 18, 2024
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.
September 18, 2024
Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors
September 17, 2024
Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes
September 17, 2024
Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multisite Single-Institution Prospective Study
September 17, 2024
Ejaculatory function after radiotherapy for prostate cancer: a systematic review and meta-analysis.
September 17, 2024
Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trial.
September 17, 2024
Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study.
September 17, 2024
Extracellular Vesicles heterogeneity through the lens of multiomics.
September 17, 2024
Prostate cancer disparities in clinical and survival patterns among Black and Latino patients considering nativity: findings from the California Cancer Registry.
September 17, 2024
Multiplex imaging of localized prostate tumors reveals altered spatial organization of AR-positive cells in the microenvironment.
September 17, 2024
MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancer.
September 17, 2024